Financial calendar
Key Financial dates:
13 September 2022
Interim results for the six months ended 30 June 2022
23 June 2022
Annual General Meeting
22 March 2022
Full year results for the year ended 31 December 2021
Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.
Learn about applications